The association between blood pressure control and long-term cardiovascular outcomes in Hypertension coexistent with obstructive sleep apnea
- PMID: 37990168
- PMCID: PMC10664294
- DOI: 10.1186/s12872-023-03595-z
The association between blood pressure control and long-term cardiovascular outcomes in Hypertension coexistent with obstructive sleep apnea
Abstract
Purpose: The goal of blood pressure (BP) control will be lower when hypertensive patients have comorbidities that can affect the risk of cardiovascular diseases. But, the goal of BP control for hypertensive patients coexistent with obstructive sleep apnea (OSA) is not discussed, which is a special population at high risk of cardiovascular diseases.
Patients and methods: Using data from a retrospective study(Urumqi Research on Sleep Apnea and Hypertension (UROSAH) study, we enrolled 3267 participants who were diagnosed with hypertension and performed polysomnography during 2011-2013 to explore the association between BP control and long-term major adverse cardiovascular and cerebrovascular event (MACCE). Outcomes of interest was the levels of BP control, MACCE, cardiac event and cerebrovascular event. Then we calculated the cumulative incidence of MACCE and performed Cox proportional hazards with stepwise models.
Results: 379 of 3267 patients experienced MACCE during a median follow-up of 7.0 years. After full risk adjustment, BP control of 120-139/80-89mmHg was associated with the lowest risk of cerebrovascular event (HR: 0.53, 95%CI:0.35-0.82) rather than MACCE and cardiac event in the total cohort. The association did not change much in patients with OSA. When the SBP and DBP were discussed separately, the SBP control of 120-139mmHg or < 120mmHg was associated with the decreased incidence of MACCE and cerebrovascular event. When DBP control < 80 mm Hg, the risk of cerebrovascular event showed 54% decrease [(HR:0.46, 95%CI: 0.25-0.88)] in patients with hypertension and OSA.
Conclusion: In this retrospective study, antihypertensive-drug-induced office and home BP control at 120-139/80-89mmHg showed possible beneficial effect on incident MACCE. However, current results need to be verified in future studies.
Keywords: Diastolic blood pressure; Major adverse cardiovascular and cerebrovascular event; Obstructive sleep apnea; Stroke.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Obstructive sleep apnea remains a risk factor for major adverse cardiovascular and cerebrovascular events even in hypertensive patients under treatment: the Urumqi Research on Sleep Apnea and Hypertension (UROSAH) data.Cardiovasc Diagn Ther. 2023 Dec 15;13(6):968-978. doi: 10.21037/cdt-23-284. Epub 2023 Dec 5. Cardiovasc Diagn Ther. 2023. PMID: 38162112 Free PMC article.
-
Non-dipping blood pressure pattern is associated with higher risk of new-onset diabetes in hypertensive patients with obstructive sleep apnea: UROSAH data.Front Endocrinol (Lausanne). 2023 Feb 16;14:1083179. doi: 10.3389/fendo.2023.1083179. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36875466 Free PMC article.
-
Major Adverse Cardiac and Cerebrovascular Events in Geriatric Patients with Obstructive Sleep Apnea: An Inpatient Sample Analysis.Med Sci (Basel). 2023 Oct 30;11(4):69. doi: 10.3390/medsci11040069. Med Sci (Basel). 2023. PMID: 37987324 Free PMC article.
-
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.Circulation. 2021 Jul 20;144(3):e56-e67. doi: 10.1161/CIR.0000000000000988. Epub 2021 Jun 21. Circulation. 2021. PMID: 34148375 Review.
-
Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022.Cardiovasc Ther. 2022 Aug 11;2022:6006127. doi: 10.1155/2022/6006127. eCollection 2022. Cardiovasc Ther. 2022. PMID: 36017216 Free PMC article. Review.
References
-
- Tietjens JR, Claman D, Kezirian EJ, De Marco T, Mirzayan A, Sadroonri B, Goldberg AN, Long C, Gerstenfeld EP, Yeghiazarians Y. Obstructive sleep apnea in Cardiovascular Disease: a review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc. 2019;8:e010440. doi: 10.1161/JAHA.118.010440. - DOI - PMC - PubMed
-
- Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial Hypertension the Task Force for the management of arterial Hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH) J Hypertens. 2023 doi: 10.1097/HJH.0000000000003480. - DOI - PubMed
-
- Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, Mehra R, Bozkurt B, Ndumele CE, Somers VK. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2021;144:e56–e67. doi: 10.1161/CIR.0000000000000988. - DOI - PubMed
-
- Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–98. doi: 10.1016/S2213-2600(19)30198-5. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical